Implications of single nucleotide polymorphisms in CD44 exon 2 for risk of breast cancer

European Journal of Cancer Prevention

Volumn 20, Issue 5, 2011, Pages 396-402

  Zhou, Juhua ^a   Nagarkatti, Prakash S ^a   Zhong, Yin ^a   Zhang, Jiajia ^b   Nagarkatti, Mitzi ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

breast cancer; CD44; gene polymorphism; patient; risk

Indexed keywords

GENOMIC DNA; HERMES ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; DISEASE ASSOCIATION; EXON; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RANK SUM TEST; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ANTIGENS, CD44; BASE SEQUENCE; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EXONS; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 80051798721     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3283463943     Document Type: Article

References (32)

1. Amir E, Freedman OC, Seruga B, Evans DG (2010). Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 102:680-691.
2. Anglian Breast Cancer Study Group (2000). Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83:1301-1308.
3. Aruffo A (1996). CD44: one ligand, two functions. J Clin Invest 98:2191-2192.
4. Bourguignon LY, Zhu D, Zhu H (1998). CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression. Front Biosci 3:d637-d649.
5. Collaborative Group on Hormonal Factors in Breast Cancer (2001). Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58209 women with breast cancer and 101 986 women without the disease. Lancet 358:1389-1399.
6. Claus EB, Risch N, Thompson WD (1991). Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48:232-242. (Pubitemid 21891587)
7. Fasching PA, Bani MR, Nestle-Kramling C, Goecke TO, Niederacher D, Beckmann MW, et al. (2007). Evaluation of mathematical models for breast cancer risk assessment in routine clinical use. Eur J Cancer Prev 16:216-224. (Pubitemid 46597425)
8. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. (1989). Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886. (Pubitemid 20026073)
9. Goodison S, Urquidi V, Tarin D (1999). CD44 cell adhesion molecules. Mol Pathol 52:189-196. (Pubitemid 29369203)
10. Gotte M, Yip GW (2006). Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 66:10233-10237. (Pubitemid 44799736)
11. Hill A, McFarlane S, Johnston PG, Waugh DJ (2006). The emerging role of CD44 in regulating skeletal micrometastasis. Cancer Lett 237:1-9.
12. Kaneko T, Saito H, Toya M, Satio T, Nakahara K, Hiroi M (2000). Hyaluronic acid inhibits apoptosis in granulosa cells via CD44. J Assist Reprod Genet 17:162-167. (Pubitemid 30484139)
13. Lesley J, Hyman R, English N, Catterall JB, Turner GA (1997). CD44 in inflammation and metastasis. Glycoconj J 14:611-622. (Pubitemid 27353205)
14. Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A (2001). Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 93:1215-1223. (Pubitemid 32816196)
15. Marhaba R, Zoller M (2004). CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol 35:211-231. (Pubitemid 40585308)
16. Nebe B, Peters A, Duske K, Richter DU, Briese V (2006). Influence of phytoestrogens on the proliferation and expression of adhesion receptors in human mammary epithelial cells in vitro. Eur J Cancer Prev 15:405-415. (Pubitemid 44252911)
17. Olsen A, Autrup H, Sorensen M, Overvad K, Tjonneland A (2008). Polymorphisms of glutathione S-transferase A1 and O1 and breast cancer among postmenopausal Danish women. Eur J Cancer Prev 17:225-229. (Pubitemid 351549662)
18. Parl FF, Dawling S, Roodi N, Crooke PS (2009a). Estrogen metabolism and breast cancer: a risk model. Ann N Y Acad Sci 1155:68-75.
19. Parl FF, Egan KM, Li C, Crooke PS (2009b). Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction. Cancer Inform 7:109-121.
20. Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A (1993). Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 122:257-264. (Pubitemid 23188816)
21. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, et al. (1999). Prevalence of BRCA1 and BRCA2 gene mutations in patients with earlyonset breast cancer. J Natl Cancer Inst 91:943-949. (Pubitemid 29272520)
22. Pinto D, Vasconcelos A, Costa S, Pereira D, Rodrigues H, Lopes C, et al. (2004). HER2 polymorphism and breast cancer risk in Portugal. Eur J Cancer Prev 13:177-181. (Pubitemid 38780673)
23. Rafi-Janajreh AQ, Nagarkatti PS, Nagarkatti M (1998). Role of CD44 in CTL and NK cell activity. Front Biosci 3:d665-d671.
24. Ready K, Litton JK, Arun BK (2010). Clinical application of breast cancer risk assessment models. Future Oncol 6:355-365.
25. So JY, Lee HJ, Smolarek AK, Paul S, Wang CX, Maehr H, et al. (2011). A novel gemini vitamin D analog represses the expression of a stem cell marker cd44 in breast cancer. Mol Pharmacol 79:360-367.
26. Telen MJ, Udani M, Washington MK, Levesque MC, Lloyd E, Rao N (1996). A blood group-related polymorphism of CD44 abolishes a hyaluronanbinding consensus sequence without preventing hyaluronan binding. J Biol Chem 271:7147-7153. (Pubitemid 26104154)
27. Thomas GJ, Speight PM (2001). Cell adhesion molecules and oral cancer. Crit Rev Oral Biol Med 12:479-498. (Pubitemid 34037727)
28. Thompson D, Easton D (2004). The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia 9:221-236. (Pubitemid 39545740)
29. Vazquez A, Grochola LF, Bond EE, Levine AJ, Taubert H, Muller TH, et al. (2010). Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival. Cancer Res 70:172-180.
30. Winder T, Ning Y, Yang D, Zhang W, Power DG, Bohanes P, et al. (2010). Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma (GA). Int J Cancer [Epub ahead of print].
31. Wu MH, Chou YC, Yu CP, Yang T, You SL, Chen CJ, et al. (2008). Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility. Eur J Cancer Prev 17:317-322.
32. Zhou J, Nagarkatti PS, Zhong Y, Creek K, Zhang J, Nagarkatti M (2010). Unique SNP in CD44 intron 1 and its role in breast cancer development. Anticancer Res 30:1263-1272.